High-Risk Histopathological Features of Retinoblastoma following Primary Enucleation: A Global Study of 1426 Patients from 5 Continents.

Autor: Kaliki S; The Operation Eyesight Institute for Eye Cancer, LV Prasad Eye Institute, Hyderabad, India., Vempuluru VS; The Operation Eyesight Institute for Eye Cancer, LV Prasad Eye Institute, Hyderabad, India., Bakal KR; The Operation Eyesight Institute for Eye Cancer, LV Prasad Eye Institute, Hyderabad, India., Dorji S; The Operation Eyesight Institute for Eye Cancer, LV Prasad Eye Institute, Hyderabad, India., Tanna V; The Operation Eyesight Institute for Eye Cancer, LV Prasad Eye Institute, Hyderabad, India., Shields CN; The Operation Eyesight Institute for Eye Cancer, LV Prasad Eye Institute, Hyderabad, India., Fallon SJ; The Operation Eyesight Institute for Eye Cancer, LV Prasad Eye Institute, Hyderabad, India., Raval V; The Operation Eyesight Institute for Eye Cancer, LV Prasad Eye Institute, Hyderabad, India., Ahmad A; Children Hospital, Lahore, Pakistan., Mushtaq A; Children Hospital, Lahore, Pakistan., Hussain M; Children Hospital, Lahore, Pakistan., Yousef YA; King Hussein Cancer Center, Amman, Jordan., Mohammad M; King Hussein Cancer Center, Amman, Jordan., Roy SR; Chittagong Eye Infirmary and Training Complex, Chittagong, Bangladesh., Huque F; Chittagong Eye Infirmary and Training Complex, Chittagong, Bangladesh., Tatiana U; Department of Surgical Methods of Treatment with chemotherapy No. 1 (Head and Neck Tumors), N. N. Blokhin National Medical Research Center of Oncology, Moscow, Russian Federation.; L.A. Durnov Department of Pediatric Oncology of the Russian Medical Academy of Continuing Professional Education, Moscow, Russian Federation., Yuri S; Department of Surgical Methods of Treatment with chemotherapy No. 1 (Head and Neck Tumors), N. N. Blokhin National Medical Research Center of Oncology, Moscow, Russian Federation., Vladimir P; Department of Surgical Methods of Treatment with chemotherapy No. 1 (Head and Neck Tumors), N. N. Blokhin National Medical Research Center of Oncology, Moscow, Russian Federation.; L.A. Durnov Department of Pediatric Oncology of the Russian Medical Academy of Continuing Professional Education, Moscow, Russian Federation.; Department of ENT Diseases of the Faculty of Pediatrics of the Federal State Educational Institution of Higher Education of N.I. Pirogov Russian National Research Medical University, Moscow, Russian Federation., Zambrano SC; Pediatric Oncology Department, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., Alarcón-León S; Pediatric Oncology Department, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., Valdiviezo-Zapata C; Pediatric Oncology Department, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., Vargas-Martorellet M; Pediatric Oncology Department, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., Gutierrez-Chira C; Pediatric Oncology Department, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., Buitrago M; Pediatric Oncology Department, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., Ortiz JS; Pediatric Oncology Department, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., Diaz-Coronado R; Pediatric Oncology Department, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.; Universidad Peruana Cayetano Heredia, Lima, Peru., Tripathy D; LV Prasad Eye Institute, Bhubaneswar, India., Rath S; LV Prasad Eye Institute, Bhubaneswar, India., Patil G; LV Prasad Eye Institute, Bhubaneswar, India., Berry JL; Children's Hospital Los Angeles & USC Roski Eye Institute, Los Angeles, USA.; Keck School of Medicine, Los Angeles, USA., Pike S; Children's Hospital Los Angeles & USC Roski Eye Institute, Los Angeles, USA.; Keck School of Medicine, Los Angeles, USA., Brown B; Children's Hospital Los Angeles & USC Roski Eye Institute, Los Angeles, USA.; Keck School of Medicine, Los Angeles, USA., Tanabe M; Kyushu University, Fukuoka, Japan., Frenkel S; Hadassah Medical Center, Jerusalem, Israel., Eiger-Moscovich M; Hadassah Medical Center, Jerusalem, Israel., Pe'er J; Hadassah Medical Center, Jerusalem, Israel., Shields CL; Ocular Oncology Service, Wills Eye Hospital, Philadelphia, USA., Eagle RC Jr; Ocular Oncology Service, Wills Eye Hospital, Philadelphia, USA., Laiton A; Ocular Oncology Service, Wills Eye Hospital, Philadelphia, USA., Velasco AM; Ocular Oncology Service, Wills Eye Hospital, Philadelphia, USA., Vega K; Ocular Oncology Service, Wills Eye Hospital, Philadelphia, USA., DeSimone J; Ocular Oncology Service, Wills Eye Hospital, Philadelphia, USA., Bejjanki KM; LV Prasad Eye Institute, Vijayawada, India., Kapoor AG; LV Prasad Eye Institute, Vijayawada, India., Venkataraman A; Royal London Hospital, Barts Health NHS Trust, London, UK., Bryant V; Royal London Hospital, Barts Health NHS Trust, London, UK., Reddy MA; Royal London Hospital, Barts Health NHS Trust, London, UK., Sagoo MS; Royal London Hospital, Barts Health NHS Trust, London, UK.; Moorfields Eye Hospital NHS Foundation Trust, London, UK.; NIHR Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital.; UCL Institute of Ophthalmology, London, UK., Hubbard GB 3rd; Emory University School of Medicine, Georgia, USA., Azarcon CP; Emory University School of Medicine, Georgia, USA., Olson TA; Emory University School of Medicine, Georgia, USA., Grossniklaus H; Emory University School of Medicine, Georgia, USA., Rolfe O; Royal Children's Hospital, Victoria Australia., Staffieri SE; Royal Children's Hospital, Victoria Australia.; Murdoch Children's Research Institute, Melbourne, Australia.; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, Australia.; University of Melbourne, Melbourne, Australia., O'Day R; Royal Children's Hospital, Victoria Australia.; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, Australia., Mathew AA; Royal Children's Hospital, Victoria Australia., Elder JE; Royal Children's Hospital, Victoria Australia.; University of Melbourne, Melbourne, Australia., McKenzie JD; Royal Children's Hospital, Victoria Australia., Fabian ID; Goldschleger Eye Institute, Sheba Medical Center, Tel Hashomer, Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel., Shemesh R; Goldschleger Eye Institute, Sheba Medical Center, Tel Hashomer, Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel., Vishnevskia-Dai V; Goldschleger Eye Institute, Sheba Medical Center, Tel Hashomer, Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel., Ali MH; The Operation Eyesight Institute for Eye Cancer, LV Prasad Eye Institute, Hyderabad, India., Jakati S; Ophthalmic Pathology Laboratory, LV Prasad Eye Institute, Hyderabad, India., Mishra DK; Ophthalmic Pathology Laboratory, LV Prasad Eye Institute, Hyderabad, India., Reddy Palkonda VA; The Operation Eyesight Institute for Eye Cancer, LV Prasad Eye Institute, Hyderabad, India.

Publikováno v: Retina (Philadelphia, Pa.) [Retina] 2024 Aug 14. Date of Electronic Publication: 2024 Aug 14.

Beyond the scalpel.

Autor: Sanjana M; Department of Ocular Oncology and Ophthalmic Plastic Surgery, Hima Bindu Yalamanchilli Centre for Eye Cancer, L. V. Prasad Eye Institute, Vijayawada, Andhra Pradesh, India., Madhuri KB, Kapoor AG

Publikováno v: Indian journal of ophthalmology [Indian J Ophthalmol] 2024 Jun 01; Vol. 72 (6), pp. 775-776. Date of Electronic Publication: 2024 May 24.

Ocular surface squamous neoplasia with orbital tumour extension: risk factors and outcomes.

Autor: Kaliki S; Operation Eyesight Universal Institute for Eye Cancer (SK, RDW, VSV), L V Prasad Eye Institute, Hyderabad, India. kalikiswathi@yahoo.com., Wagh RD; Operation Eyesight Universal Institute for Eye Cancer (SK, RDW, VSV), L V Prasad Eye Institute, Hyderabad, India., Vempuluru VS; Operation Eyesight Universal Institute for Eye Cancer (SK, RDW, VSV), L V Prasad Eye Institute, Hyderabad, India., Kapoor AG; Hima Bindu Yalamanchili Centre for Eye Cancer (AGK), L V Prasad Eye Institute, Vijayawada, India., Jakati S; Ophthalmic Pathology Laboratory (SJ, DKM), L V Prasad Eye Institute, Hyderabad, India., Mishra DK; Ophthalmic Pathology Laboratory (SJ, DKM), L V Prasad Eye Institute, Hyderabad, India., Mohamed A; Ophthalmic Biophysics (AM), L V Prasad Eye Institute, Hyderabad, India.

Publikováno v: Eye (London, England) [Eye (Lond)] 2023 Feb; Vol. 37 (3), pp. 446-452. Date of Electronic Publication: 2022 Feb 03.

Neurotization of the human cornea - A comprehensive review and an interim report.

Autor: Rathi A; The Cornea Institute, KAR Campus; Centre for Rare Eye Diseases and Ocular Genetics, L V Prasad Eye Institute, Hyderabad, Telangana, India., Bothra N; Ophthalmic Plastic Surgery Service, L V Prasad Eye Institute; Centre for Rare Eye Diseases and Ocular Genetics, L V Prasad Eye Institute, Hyderabad, Telangana, India., Priyadarshini SR; The Cornea Institute, MTC Campus, Bhubaneswar, Odisha, India., Achanta DSR; The Cornea Institute, KAR Campus; Centre for Rare Eye Diseases and Ocular Genetics, L V Prasad Eye Institute, Hyderabad, Telangana, India., Fernandes M; The Cornea Institute, KAR Campus, Hyderabad, Telangana; The Cornea Institute, GMRV Campus, L V Prasad Eye Institute, Vijayawada, Andhra Pradesh, India., Murthy SI; The Cornea Institute, KAR Campus, Hyderabad, Telangana, India., Kapoor AG; Ophthalmic Plastic Surgery and Aesthetics, Ocular Oncology, KVC Campus, L V Prasad Eye Institute, Vijayawada, Andhra Pradesh, India., Dave TV; Ophthalmic Plastic Surgery Service, L V Prasad Eye Institute, Hyderabad, Telangana, India., Rath S; Ophthalmic Plastic Surgery and Aesthetics, Ocular Oncology, L V Prasad Eye Institute, Bhubaneswar, Odisha, India., Yellinedi R; Basavatarakam, Indo American Cancer Hospital and Research Institute, Hyderabad, Telangana, India., Nuvvula R; Basavatarakam, Indo American Cancer Hospital and Research Institute, Hyderabad, Telangana, India., Dendukuri G; Ophthalmic Plastic Surgery, Aesthetics and Faciomaxillary Surgery Service, L V Prasad Eye Institute, Hyderabad, Telangana, India., Naik MN; Ophthalmic Plastic Surgery Service, L V Prasad Eye Institute, Hyderabad, Telangana, India., Ramappa M; The Cornea Institute, KAR Campus; Centre for Rare Eye Diseases and Ocular Genetics, L V Prasad Eye Institute; Jasti V Ramanamma Children's Eye Care Center, L V Prasad Eye Institute, Hyderabad, Telangana, India.

Publikováno v: Indian journal of ophthalmology [Indian J Ophthalmol] 2022 Jun; Vol. 70 (6), pp. 1905-1917.

Ocular Surface Squamous Neoplasia With Coexistent Microbial Keratitis: Incidence, Risk Factors, Clinical Features, Microbiological Profile, and Treatment Outcome.

Autor: Kapoor AG; Hima Bindu Yalamanchili Centre for Eye Cancer, LV Prasad Eye Institute, Vijayawada, India., Vempuluru VS; The Operation Eyesight Universal Institute for Eye Cancer, L V Prasad Eye Institute, Hyderabad, India., Laghimshetty S; Hima Bindu Yalamanchili Centre for Eye Cancer, LV Prasad Eye Institute, Vijayawada, India., Roy A; The Cornea Institute, L V Prasad Eye Institute, Vijayawada, India., Sharma S; Jhaveri Microbiology Centre, L V Prasad Eye Institute, Hyderabad, India., Mishra DK; Ophthalmic Pathology Laboratory, L V Prasad Eye Institute, Hyderabad, India; and., Mohamed A; Ophthalmic Biophysics, L V Prasad Eye Institute, Hyderabad, India., Kaliki S; The Operation Eyesight Universal Institute for Eye Cancer, L V Prasad Eye Institute, Hyderabad, India.

Publikováno v: Cornea [Cornea] 2022 Mar 01; Vol. 41 (3), pp. 294-303.